Failure PatternDecision layer
Why Agencies Fail With Blaze in Healthcare Delivery: The Enterprise White-Label Assumption Trap
Symptom: Agency quotes a client a white-labeled patient portal at Production plan pricing ($750/month) and discovers custom branding and white-labeling only exist under Enterprise, which requires direct sales negotiation with no published rate. Root cause: Blaze's white-label and custom branding capability sits behind the Enterprise tier, which is contact-sales only, so agencies cannot quote a resale margin from published pricing and routinely underbid.
By InnovaAI ResearchPublished
How do you recognize it?
- •Agency quotes a client a white-labeled patient portal at Production plan pricing ($750/month) and discovers custom branding and white-labeling only exist under Enterprise, which requires direct sales negotiation with no published rate
- •Client asks for a second published app mid-engagement and the agency realizes Production caps at 1 published app and 100 end users, forcing an unplanned jump to Growth at $2,500/month
- •Agency builds a proof-of-concept on the Internal Apps plan at $1,350/year, then cannot migrate it cleanly to a client-facing Production environment because internal-user licensing does not cover external patients
- •Delivery team spends weeks on a FHIR integration assumption before confirming the client's EHR is actually Athenahealth or FHIR-compliant, and the connection stalls
- •Retainer scope creeps past 100 end users on a live clinic app, triggering either a plan upgrade conversation the agency never priced or a hard user cap during peak intake periods
Why does it happen?
- •Blaze's white-label and custom branding capability sits behind the Enterprise tier, which is contact-sales only, so agencies cannot quote a resale margin from published pricing and routinely underbid
- •The published tiers are gated by published apps and end-user counts (1 app and 100 users on Production, 5 apps and 1,000 users on Growth), and agencies scope fixed-fee builds without mapping client growth to those ceilings
- •Native integrations are specific (Athenahealth, OpenAI, FHIR-compliant systems), not universal EHR coverage, so agencies assume interoperability that the platform does not provide for a given client's stack
- •Internal Apps licensing is priced for internal users and apps, which makes it attractive for prototypes but does not translate into a client-facing deployment model without a separate Production or Growth commitment
How do you fix it?
- •Open a Blaze sales conversation for Enterprise white-label terms before signing any client contract that promises branded portals, and write the negotiated rate into the SOW as a pass-through line
- •Audit every active client app in the Blaze admin console against its plan's published app and end-user limits, then flag any account within 20 percent of its ceiling for a pre-agreed upgrade path
- •Confirm the client's EHR vendor and FHIR compliance in writing during discovery, and scope Athenahealth or FHIR integration only where the Blaze native connector actually applies
- •Rebuild prototype work from the Internal Apps environment into a Production-plan app before client go-live, and document the migration steps so delivery hours are estimated rather than absorbed
More on Blaze
- StrategyWhy Blaze Turns Healthcare Compliance Into Agency Margin
- ConceptBlaze Compliance Ceiling
- Evaluation RuleBlaze Rule: Price the BAA and the User Ceiling Before You Pitch a Healthcare Client
- Decision FrameworkBlaze: Buy vs Skip (Healthcare Client Work Without an Engineering Team)
- Implementation BlueprintBlaze HIPAA Intake App Sprint (7-10 days)
- Operating ProcedureBlaze Client Workspace Provisioning (Onboarding)